Maximizing Outcomes: The Impact of Oral Medications on Weight Management
Target Audience: Pharmacist, Pharmacy Tech, Physician Assistant, Physician
Course Overview
Oral anti-obesity medications (AOMs) serve as valuable tools in the management of obesity. Current guidelines advocate for a multimodal approach to obesity treatment, incorporating lifestyle interventions such as diet and exercise alongside pharmacotherapy when appropriate. The decision to initiate an oral AOM should be tailored to the patient's weight-loss goals, comorbidities, and the medication's safety profile. This educational activity provides an in-depth review of the mechanisms of action, dosing strategies, and the efficacy and safety profiles of oral AOMs. Additionally, this activity emphasizes the critical role of long-term monitoring, shared decision-making, and interprofessional collaboration in ensuring these therapies are used safely and effectively to optimize patient outcomes.
Learning Objectives
Upon completion of this educational activity, participants should be able to:
- Compare and Contrast the mechanisms of oral anti-obesity medications (AOMs) in weight management
- Describe the efficacy and safety of oral AOMs
- Identify interprofessional collaboration strategies to optimize treatment outcomes
- Educate patients on the appropriate use of oral AOMs
Faculty
- Introduction
- Mechanisms and Effectiveness of Oral AOMs
- Orlistat
- Phentermine
- Phentermine-Topiramate
- Naltrexone-Bupropion
- Comparison of Anti-Obesity Drugs for Obesity Management
- Initiating and Stopping Oral AOMs
- Initiating Oral AOMs
- Evaluating Treatment Response and Stopping Rules
- Discontinuing Oral AOMs and Managing Weight Regain
- The Role of Collaborative Practice Models in Obesity Treatment
- Access, Affordability, and Adherence Challenges
- Summary
From March 30, 2026 through March 30, 2029, participants must:
- Read the "learning objectives" and "author and planning team disclosures"
- Study the section entitled "educational activity"
- Complete the Course Test and Evaluation form. The Course Test will be graded automatically. Following successful completion of the Course Test with a score of 70% or higher, a statement of participation will be made available immediately. (No partial credit will be given.)
Credit for this course will be automatically uploaded to CPE Monitor®.
Faculty Planner Disclosure
The following individuals were involved in developing this activity: L. Austin Fredrickson, MD, FACP, Liz Fredrickson, PharmD, BCPS; Susan Bowlin, DNP, FNP-BC, ACNP-BC, CBN; and Pamela Sardo, PharmD, BS. Austin Frederickson, Liz Frederickson, and Pamela Sardo have no conflict of interest or financial relationship or commercial or financial support relevant to this activity to report or disclose in the development of this activity. Susan Bowlin is a member of the Speaker's Bureau for Eli Lilly and Novo Nordisk. Any potential conflicts of interest were mitigated.
Unlabeled Use Disclosure
The information provided in this course is general in nature, and it is designed solely to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant's professional practice, including but not limited to patient assessment, diagnosis, treatment, and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals must consult their employer, healthcare facility, hospital, or other organization for guidelines, protocols, and procedures to follow. The information provided in this course does not replace those guidelines, protocols, and procedures, but is for academic purposes only, and this course's limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses is constantly changing. Any person taking this course understands that such a person must make an independent review of medication information before any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only, and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course or course material.
Please ensure the device you plan to use meets these requirements:
- Operating System: Windows 7, 8, 10, or 11 / Mac OS X 10.9 or later / iOS / Android
- Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
- A connection to the internet
Accreditation
In support of improving patient care, RxCE.com is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PTCB Recognition
RxCe.com, LLC, offers pharmacy technician continuing education courses for PTCB recertification. Pharmacy technician courses are indicated both in the Target Audience description and the ACPE UAN which will end with a "T".